Stock Taper
NIKI
NIKI BIOSOLUTIONS, INC.
NASDAQ
$8.58
▲ UP 4.63% (0.38)

KEY STATISTICS

Market Cap$698.73 K
52w High$26.50
52w Low$6.00
Dividend Yield
Frequency
P/E
Volume30.46K
Shares Out.81.44K

COMPANY

LEADERSHIP

Chung Yuen Huen
CHIEF EXECUTIVE
Chung Yuen Huen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 20, 2026
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
1

SPLIT RECORD

DATETYPERATIO
2026-07-20Reverse1:10

PRICE

$8.58 ▲ UP 4.63% (+$0.38)
OVERLAYS
$8.00$8.40$8.80$9.209:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM8.58

About Niki BioSolutions, Inc.

https://www.aptorumgroup.com ↗

Niki BioSolutions, formed from Aptorum Group and DiamiR Biosciences, develops therapeutic and diagnostic products for unmet medical needs in oncology, infectious diseases, and brain health.

INDUSTRY

Biotechnology

A PRODUCT NIKI BIOSOLUTIONS, INC. IS KNOWN FOR

CogniMIR
CogniMIR

A blood-based diagnostic test in late-stage development for early detection of synaptic loss and neurodegeneration related to mild cognitive impairment and Alzheimer's progression, utilizing brain-enriched microRNA biomarkers, following the compan...

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

DIRECTOR
Arner Douglas Wayne
· —
2026-07-20
DIRECTOR
Wu Justin Che Yuen
· —
2026-07-20
OFFICER
Mireskandari Alidad
· —
2026-07-20
DIRECTOR
Philips Laura A
· —
2026-07-20